Infliximab-Induced Aseptic Meningitis in a Patient with Crohnʼs Disease
Authors:
Open Access
- 1 January 2018
- journal article
- research article
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 5 (1) , e48
Abstract
Infliximab is an anti-tumor necrosis factor α (TNFα) monoclonal antibody that treats moderate-to-severe Crohn's disease. In rare cases, infliximab has been associated with drug-induced aseptic meningitis. We present a 46-year-old woman with migraines and inflammatory Crohn's colitis treated with intravenous infliximab and methotrexate. She developed nuchal rigidity, photophobia, and headache 2 days after each of her infliximab infusions, with symptom resolution 1 week post-infusion. Her exam, imaging, and cerebrospinal fluid analysis were consistent with drug-induced aseptic meningitis. She discontinued infliximab and started vedolizumab with continued remission of her Crohn's disease.Keywords
This publication has 13 references indexed in Scilit:
- Infliximab-induced aseptic meningitisThe American Journal of Emergency Medicine, 2014
- The Challenge of Drug-Induced Aseptic Meningitis RevisitedJAMA Internal Medicine, 2014
- Case report of aseptic meningitis in a patient with Crohnʼs disease under infliximab therapyInflammatory Bowel Diseases, 2011
- Management of Crohn's Disease in AdultsAmerican Journal of Gastroenterology, 2009
- Lymphocytic meningitis with infliximab for ulcerative colitisGastroentérologie Clinique Et Biologique, 2006
- Fatal aseptic meningoencephalitis following infliximab treatment for inflammatory bowel disease: Figure 1Gut, 2006
- Infliximab-induced Headache and Infliximab-induced Meningitis: Two Ends of the Same Spectrum?Southern Medical Journal, 2005
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Infliximab-induced aseptic meningitisThe Lancet, 2001
- Intravenous Immune Globulin and Aseptic MeningitisArchives of Pediatrics & Adolescent Medicine, 1992